Antibody Discovery & Development

The YUMAB® platform provides all technologies for a fully integrated human antibody development in one company. We offer individually designed, work package-based contract research projects from your target molecule to your engineered and optimized antibody lead candidate. Single technology modules or combinations thereof are also available as R&D service to assist your antibody program at every stage.

Antibody-Discovery-Development

The YUMAB® platform includes three core technologies:

  • Hit Discovery: Generation of unique specific antibody Hits for your target structure that bind in your designated assay.
  • Lead Engineering: Optimization of selected antibody Hits with the most promising binding characteristics with respect to affinity, specificity, selectivity or stability into early antibody lead candidates.
  • Lead Development: Identification of the most developable early lead candidates and final polishing of the antibody sequences to your final lead candidate(s) for cell line development.

Contact

YUMAB GMBH
Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany

Email: info@yumab.com
Phone: +49 531 481170-0